sprite-preloader
Anzeige
Mehr »
Montag, 21.08.2017 Börsentäglich über 12.000 News von 560 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19:09Hikma jacks up a handful of drug prices as much as 430%
19:09Ironwood's gout franchise gets a lift with Duzallo combo OK
18:09Pfizer lashes out at 'frustrating' NICE decision on Besponsa
17:09Novartis CEO opens door to patient urging 'fair' CAR-T pricing
17:09Siri? Alexa? The doctor will see you now
17:09Sanofi enlists WPP to join Publicis, Havas in agency lineup
17:09Dr. Reddy's rolls new ads to relaunch ex-Novartis OTC brands
FrThank Ken Frazier for making pharma look good
FrFiercePharmaAsia-Zai Lab, Takeda, Fosun and Shanghai Pharma
FrAstraZeneca's Lynparza ready for fight on Tesaro's turf
FrLawmakers dig into 'skyrocketing' MS drug costs
DoMylan completes $465M DOJ settlement tied to EpiPen
DoPfizer wins approval for blood cancer drug Besponsa
DoShkreli thinks he will escape prison on fraud convictions
DoValeant denies stealing trade secrets in M&A bid for lens tech
DoNovo grabs edge over Trulicity with new semaglutide data
DoValeant says FDA has noted improvement at Bausch + Lomb plant
DoRecord $187B in lifetime sales leads decade's top patent losses
MiOpdivo-Yervoy combo hits and misses in kidney cancer trial
MiBiocon pulls EU Herceptin biosimilar, will resubmit next quarter
MiJ&J CEO Gorsky says he'll stay on Trump panel
MiPharma's social status: LinkedIn and FB up, Twitter down
MiPayers line up to back pricey new ALS med Radicava
MiAlexion wins new Soliris patents for super-expensive drug
MiFDA: Drug ad viewers find short list of risks easier to recall